Mohamedkhan, S.; Hindocha, S.; de Boisanger, J.; Millard, T.; Welsh, L.; Rich, P.; MacKinnon, A.D.; Williams, N.; Sharma, B.; Rosenfelder, N.;
et al. Contrast Clearance Analysis (CCA) to Assess Viable Tumour following Stereotactic Radiosurgery (SRS) to Brain Metastasis in Non-Small Cell Lung Cancer (NSCLC). Cancers 2024, 16, 1218.
https://doi.org/10.3390/cancers16061218
AMA Style
Mohamedkhan S, Hindocha S, de Boisanger J, Millard T, Welsh L, Rich P, MacKinnon AD, Williams N, Sharma B, Rosenfelder N,
et al. Contrast Clearance Analysis (CCA) to Assess Viable Tumour following Stereotactic Radiosurgery (SRS) to Brain Metastasis in Non-Small Cell Lung Cancer (NSCLC). Cancers. 2024; 16(6):1218.
https://doi.org/10.3390/cancers16061218
Chicago/Turabian Style
Mohamedkhan, Shybi, Sumeet Hindocha, James de Boisanger, Thomas Millard, Liam Welsh, Philip Rich, Andrew D. MacKinnon, Nicholas Williams, Bhupinder Sharma, Nicola Rosenfelder,
and et al. 2024. "Contrast Clearance Analysis (CCA) to Assess Viable Tumour following Stereotactic Radiosurgery (SRS) to Brain Metastasis in Non-Small Cell Lung Cancer (NSCLC)" Cancers 16, no. 6: 1218.
https://doi.org/10.3390/cancers16061218
APA Style
Mohamedkhan, S., Hindocha, S., de Boisanger, J., Millard, T., Welsh, L., Rich, P., MacKinnon, A. D., Williams, N., Sharma, B., Rosenfelder, N., & Minchom, A.
(2024). Contrast Clearance Analysis (CCA) to Assess Viable Tumour following Stereotactic Radiosurgery (SRS) to Brain Metastasis in Non-Small Cell Lung Cancer (NSCLC). Cancers, 16(6), 1218.
https://doi.org/10.3390/cancers16061218
